ストックスクリーナーアプリを入手
95.15
1.82%
1.68
Spdr Biotech Etf (XBI) 最新ニュース
Biotech Stocks Rise 3.8% as SPDR S&P Biotech ETF Hits Two-Month High - geneonline.com
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
(XBI) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
Liquidity Mapping Around (XBI) Price Events - news.stocktradersdaily.com
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
How (XBI) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
XBI ETF Implied Analyst Target Price: $139.15 per unit, with 54.74% upside from current price of $89.92 per unit. - AInvest
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Noteworthy ETF Inflows: XBI, ALNY, HALO, INSM - Nasdaq
(XBI) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
Exploring the SPDR S&P Biotech ETF (XBI) for Biotech Industry Exposure - AInvest
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Assessing the Political and Policy Risks in the 2028 U.S. Presidential Race and Their Impact on Health and Biotech Sectors - AInvest
Health and Human Services Secretary Robert F. Kennedy Jr. Disavows 2028 Presidential Run, Pledges Loyalty to Trump. - AInvest
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
7 Best Biotech ETFs to Buy Now - US News Money
ETF Talk: Create the Future with This ETF - Stock Investor
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF - Nasdaq
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 of the Best AI ETFs to Buy for 2025 - US News Money
Prasad’s FDA Return Adds to Leadership Turmoil at U.S. Health Agencies - Barron's
FDA Leadership Shifts and Their Impact on Biotech Valuations: Navigating Regulatory Risk in the Post-Vinay Prasad Era - AInvest
Regulatory Leadership Volatility: How FDA Reinstatements Reshape Biotech Investment Landscapes - AInvest
The AI-Driven Medtech Revolution: Why Heartflow's IPO Signals a Strategic Buy in a Shifting Market - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
QQQ Tops Daily ETF Inflows - ETF.com
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
The World’s First AI Genome Editor - Brownstone Research
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
(08/04/25) BBH: A Biotech Fund That’s Ripe for a Major Turnaround - moneyshow.com
0.54%
0.08%
大文字化:
|
ボリューム (24 時間):